Journal of Urologic Oncology

Search

Page Path

HOME
Search

Erratum: Addition of the second author

Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer: Ja Yoon Ku, Md Nazmul Huda, Eu Chang Hwang, Chan Ho Lee, Kyung Hwan Kim, Dong Deuk Kwon, Hong Koo Ha; Journal of Urologic Oncology. 2023;21(3):277-277. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.err.kjuo.2022.20.1.52
Corrects: 2022;20(1):52; Full text PubReader ePub PDF

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

MOST READ MOST CITED

6,025	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
5,499	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
5,007	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
4,841	Complex Epidemiology of Prostate Cancer in Asian Countries
4,692	The Present and Future of Intravesical Therapy in Bladder Cancer

Cited By 9	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 4	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 4	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use

Editorial Office: Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817, FAX: +82-2-742-4665 Email: journal@e-juo.org

Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: kspe.editor@gmail.com

Copyright © The Korean Urological Oncology Society.